UCMYM802
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCMYM802, covering 2024-07-24 to 2024-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors [Phase 1]